Tci Wealth Advisors, Inc. Bridge Bio Pharma, Inc. Transaction History

Tci Wealth Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$7.17 - $18.55 $1,319 - $3,413	184 Added 41.07%	632 $10,000
Q4 2022 Feb 06, 2023	SELL	$6.74 - $11.52 $6 - $11	-1 Reduced 0.22%	448 $3,000
Q3 2022 Nov 08, 2022	BUY	$7.94 - $12.36 $7 - $12	1 Added 0.22%	449 $4,000
Q2 2022 Jul 19, 2022	BUY	$5.21 - $12.14 $2,334 - $5,438	448 New	448 $4,000
Q4 2021 Jan 24, 2022	SELL	$11.38 - $53.41 $1,718 - $8,064	-151 Closed	0 $0
Q2 2021 Aug 02, 2021	BUY	$46.47 - $63.93 $3,252 - $4,475	70 Added 86.42%	151 $9,000
Q1 2021 Apr 29, 2021	BUY	$55.47 - $72.35 $4,493 - $5,860	81 New	81 $5,000
Q1 2020 Apr 14, 2020	SELL	$16.11 - $36.23 $451 - $1,014	-28 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$17.96 - $46.63 $502 - $1,305	28 New	28 $1,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.